InflaRx Price To Sales Ratio from 2010 to 2024
| IFRX Stock | USD 2.36 0.05 2.16% |
Price To Sales Ratio | First Reported 2010-12-31 | Previous Quarter 1.2 K | Current Value 788.01 | Quarterly Volatility 289.667549 |
Check InflaRx NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InflaRx NV's main balance sheet or income statement drivers, such as Interest Income of 3.2 M, Discontinued Operations of 0.0 or Depreciation And Amortization of 342.2 K, as well as many indicators such as Price To Sales Ratio of 788, Dividend Yield of 0.0 or PTB Ratio of 0.83. InflaRx financial statements analysis is a perfect complement when working with InflaRx NV Valuation or Volatility modules.
InflaRx | Price To Sales Ratio |
Latest InflaRx NV's Price To Sales Ratio Growth Pattern
Below is the plot of the Price To Sales Ratio of InflaRx NV over the last few years. Price to Sales Ratio is figured by comparing InflaRx NV stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on InflaRx NV sales, a figure that is much harder to manipulate than other InflaRx NV multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. InflaRx NV's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in InflaRx NV's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1,317 X | 10 Years Trend |
|
Price To Sales Ratio |
| Timeline |
InflaRx Price To Sales Ratio Regression Statistics
| Arithmetic Mean | 923.42 | |
| Geometric Mean | 883.39 | |
| Coefficient Of Variation | 31.37 | |
| Mean Deviation | 271.49 | |
| Median | 685.82 | |
| Standard Deviation | 289.67 | |
| Sample Variance | 83,907 | |
| Range | 598 | |
| R-Value | 0.69 | |
| Mean Square Error | 47,364 | |
| R-Squared | 0.48 | |
| Significance | 0 | |
| Slope | 44.68 | |
| Total Sum of Squares | 1.2M |
InflaRx Price To Sales Ratio History
About InflaRx NV Financial Statements
InflaRx NV investors use historical fundamental indicators, such as InflaRx NV's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in InflaRx NV. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Price To Sales Ratio | 1.2 K | 788 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.